{"id":"W1992624894","doi":"10.1097/jto.0000000000000318","title":"Patient-Reported Outcomes and Quality of Life in PROFILE 1007: A Randomized Trial of Crizotinib Compared with Chemotherapy in Previously Treated Patients with ALK-Positive Advanced Non–Small-Cell Lung Cancer","year":2014,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"Pfizer","keywords":"Medicine; Crizotinib; Pemetrexed; Docetaxel; Lung cancer; Internal medicine; Quality of life (healthcare); Oncology; Performance status; ALK inhibitor; Chemotherapy; Physical therapy; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001158392,0.001323554,0.002566327,0.0003287575,0.000321768,0.001027169,0.0008174505,0.001159588,0.004152561],"category_scores_gemma":[0.001713463,0.0005138872,0.002562906,0.0004404028,0.0008862401,0.0007524427,0.0005137657,0.003377227,0.0004768949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001281,"about_ca_system_score_gemma":0.0009490561,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002058609,"about_ca_topic_score_gemma":0.004563852,"domain_scores_codex":[0.9990433,0.0005314882,0.00005858795,0.0001618857,0.00006778494,0.0001369974],"domain_scores_gemma":[0.9991741,0.0002148996,0.0002658909,0.0000529648,0.00003643472,0.0002557517],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.984528,0.001892285,0.001841208,0.0002680868,0.001946264,0.00002433605,0.00001925313,0.0004154792,0.001133619,0.00005497383,0.000366466,0.007510099],"study_design_scores_gemma":[0.9150667,0.07107759,0.009496466,0.00004177658,0.002252776,0.00004546107,0.00004365053,0.001029759,0.000384208,0.0001742096,0.0003627212,0.00002471513],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947132,0.002318226,0.0001528314,0.0004551317,0.0001923268,0.0004811228,0.0006572736,0.00003473683,0.0009949725],"genre_scores_gemma":[0.9961279,0.0009193766,0.000317516,0.0003803857,0.0001528084,0.0006693226,0.0007440341,0.000008935189,0.0006797593],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004152561,"threshold_uncertainty_score":0.0138917,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01542092926780004,"score_gpt":0.4012637173132929,"score_spread":0.3858427880454929,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}